Teleflex Incorporated $TFX Shares Bought by T. Rowe Price Investment Management Inc.

Key Points

• T. Rowe Price Investment Management Inc. raised its stake in Teleflex by 0.7%, owning 14.07% of the company, which is valued at approximately $859 million.
• Teleflex reported a quarterly earnings per share (EPS) of $3.73, surpassing estimates and showing a 4.2% increase in revenue year-over-year.
• The company announced a $0.34 quarterly dividend, with a payout ratio of 32%, to be paid on September 15th.

T. Rowe Price Investment Management Inc. boosted its holdings in Teleflex Incorporated (NYSE:TFX - Free Report) by 0.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,216,763 shares of the medical technology company's stock after acquiring an additional 43,642 shares during the quarter. T. Rowe Price Investment Management Inc. owned 14.07% of Teleflex worth $859,095,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Mariner LLC increased its holdings in Teleflex by 7.9% in the 4th quarter. Mariner LLC now owns 5,430 shares of the medical technology company's stock worth $966,000 after buying an additional 396 shares in the last quarter. Marshall Wace LLP increased its holdings in Teleflex by 8.4% in the 4th quarter. Marshall Wace LLP now owns 55,087 shares of the medical technology company's stock worth $9,804,000 after buying an additional 4,284 shares in the last quarter. Canada Pension Plan Investment Board increased its holdings in Teleflex by 137.2% in the 4th quarter. Canada Pension Plan Investment Board now owns 22,300 shares of the medical technology company's stock worth $3,969,000 after buying an additional 12,900 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in Teleflex by 0.4% in the 4th quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock worth $3,614,000 after buying an additional 74 shares in the last quarter. Finally, Forum Financial Management LP increased its holdings in Teleflex by 48.6% in the 4th quarter. Forum Financial Management LP now owns 1,293 shares of the medical technology company's stock worth $230,000 after buying an additional 423 shares in the last quarter. 95.62% of the stock is owned by institutional investors.

Insider Activity

In other Teleflex news, CEO Liam Kelly acquired 1,500 shares of the business's stock in a transaction that occurred on Tuesday, August 5th. The stock was purchased at an average cost of $115.07 per share, with a total value of $172,605.00. Following the transaction, the chief executive officer owned 45,267 shares of the company's stock, valued at $5,208,873.69. This trade represents a 3.43% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Andrew A. Krakauer acquired 1,000 shares of the company's stock in a transaction dated Tuesday, August 5th. The stock was purchased at an average cost of $115.25 per share, with a total value of $115,250.00. Following the completion of the purchase, the director directly owned 7,192 shares of the company's stock, valued at approximately $828,878. This represents a 16.15% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 5,500 shares of company stock worth $633,590. Insiders own 1.40% of the company's stock.

Teleflex Stock Performance

Shares of TFX stock traded down $0.9650 during mid-day trading on Monday, reaching $128.4550. The stock had a trading volume of 131,638 shares, compared to its average volume of 787,373. The business's fifty day moving average is $118.15 and its 200-day moving average is $130.33. The company has a current ratio of 2.41, a quick ratio of 1.44 and a debt-to-equity ratio of 0.42. The firm has a market cap of $5.68 billion, a price-to-earnings ratio of 30.22, a PEG ratio of 1.80 and a beta of 1.08. Teleflex Incorporated has a 1-year low of $108.90 and a 1-year high of $249.90.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.36 by $0.37. Teleflex had a return on equity of 15.08% and a net margin of 6.31%.The company had revenue of $780.90 million for the quarter, compared to the consensus estimate of $771.53 million. During the same quarter in the prior year, the business posted $3.42 earnings per share. Teleflex's revenue for the quarter was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. On average, research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, September 15th. Investors of record on Friday, August 15th will be given a dividend of $0.34 per share. The ex-dividend date is Friday, August 15th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio (DPR) is presently 32.00%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Wall Street Zen raised Teleflex from a "hold" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Morgan Stanley reduced their price objective on Teleflex from $191.00 to $173.00 and set an "overweight" rating on the stock in a research note on Monday, May 5th. Truist Financial reduced their price target on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research report on Monday, May 5th. Royal Bank Of Canada raised their price target on Teleflex from $130.00 to $135.00 and gave the stock a "sector perform" rating in a research report on Friday, August 1st. Finally, Wells Fargo & Company lowered their price target on Teleflex from $137.00 to $131.00 and set an "equal weight" rating for the company in a research report on Friday, August 1st. One equities research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $141.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.